SCHEMBL4131247

SCHEMBL4131247

Cc1ccccc1OS(=O)(=O)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.58
MAPT P10636 2/20 0.50
METAP2 P50579 1/20 0.50
METAP1 P53582 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
LMNA P02545 2/20 0.49
HTR6 P50406 2/20 0.49
ALPL P05186 1/20 0.48
TDP1 Q9NUW8 2/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
MAPK1 P28482 1/20 0.46
HSD11B1 P28845 1/20 0.46
HSD17B3 P37058 1/20 0.46
ESR1 P03372 2/20 0.45
GAA P10253 2/20 0.45
ESR2 Q92731 2/20 0.45
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trimethylammonium SCHEMBL27815678 0.94 ALDH1A1 (0.53) ALDH1A1MAPTMETAP2METAP1L3MBTL1
SCHEMBL3824499 0.89 LMNA (0.59) ALDH1A1MAPTLMNAHTR6MEN1
SCHEMBL29586241 0.89 LMNA (0.59) ALDH1A1MAPTLMNAHTR6MEN1
SCHEMBL11141465 0.85 HSD11B1 (0.49) ALDH1A1MAPTL3MBTL1LMNAHTR6
SCHEMBL5860749 0.85 HSD11B1 (0.53) ALDH1A1MAPTLMNAMEN1KMT2A
SCHEMBL31272384 0.85 ALDH1A1 (0.68) ALDH1A1MAPTMETAP2METAP1L3MBTL1
SCHEMBL8818918 0.84 LMNA (0.58) ALDH1A1L3MBTL1LMNAALPLTDP1
SCHEMBL8820649 0.81 ALPL (0.51) ALDH1A1MAPTLMNAALPLMEN1
SCHEMBL30153300 0.81 ALDH1A1 (0.42) ALDH1A1MAPTMETAP2METAP1L3MBTL1
SCHEMBL31500924 0.80 ALDH1A1 (0.62) ALDH1A1MAPTMETAP2METAP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12100809-B2 Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2024-09-24 US disclosed
US-20220149436-A1 NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2022-05-12 US disclosed
US-11283107-B2 Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2022-03-22 US disclosed
EP-3621141-A1 NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2020-03-11 EP disclosed
US-20190229372-A1 NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2019-07-25 US disclosed
US-10333172-B2 Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2019-06-25 US disclosed
US-10290901-B2 2019-05-14 US disclosed
US-20170084955-A1 NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2017-03-23 US disclosed
US-20150056503-A1 NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2015-02-26 US disclosed
CN-102712576-B Method for producing aromatic formamides BASF SE 2014-11-19 CN disclosed
WO-2012142698-A1 ALKYLUREA DERIVATIVES ACTIVE AGAINST CANCER CELLS UNIVERSITE LAVAL (CA) 2012-10-26 WO disclosed
CN-102712576-A Method for producing aromatic formamides BASF SE 2012-10-03 CN disclosed
US-8273685-B2 Agrochemical composition NIPPON SODA CO., LTD. (JP) 2012-09-25 US disclosed
US-20090286682-A1 AGROCHEMICAL COMPOSITION NIPPON SODA CO., LTD. (JP) 2009-11-19 US disclosed
EP-2012386-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY Mitsubishi Chemical Corporation (JP) 2009-01-07 EP disclosed
CN-1249790-C Ray sensitive compasition for preparing insulation film and display JSR CORP (JP) 2006-04-05 CN disclosed
CN-1445315-A Ray sensitive compasition for preparing insulation film and display JSR CORP (JP) 2003-10-01 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286682-A1 AGROCHEMICAL COMPOSITION DEGS1, PFAS, SGMS1 ALDH1A1 3991/4885MAPT 1104/4885METAP2 3389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.